We are live on ! Find out more
IVF

INVO Fertility Inc

9 hedge funds and large institutions have $4.88M invested in INVO Fertility Inc in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

29% more funds holding

Funds holding: 79 (+2)

0% more ownership

Funds ownership: 0%0% (0%)

20% less capital invested

Capital invested by funds: $6.14M → $4.88M (-$1.25M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $72K

Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
Closed
1
Calls
Puts
$72K
Net Calls
-$72K
Net Calls Change
-$28K

IVF Hedge Fund Activity: Q1 2022 in Review

9 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in INVO Fertility Inc (IVF) for Q1 2022, worth a combined $4.88M — down 20% from $6.14M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new IVF positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $86.7K. The largest seller was Perritt Capital Management, exiting entirely with an estimated $260K sold.

  • 9 institutional investors held INVO Fertility Inc (IVF) as of Q1 2022, up from 7 in Q4 2021.
  • Funds reported $4.88M of INVO Fertility Inc stock for Q1 2022, down 20% quarter-over-quarter.
  • 3 funds opened new INVO Fertility Inc positions in Q1 2022 and 1 closed out, a net change of +2 holders.
  • The largest INVO Fertility Inc buyer in Q1 2022 was Citadel Advisors, an estimated $86.7K added.
  • The largest INVO Fertility Inc seller in Q1 2022 was Perritt Capital Management, an estimated $260K sold.

Based on aggregated 13F filings for Q1 2022.